Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03905148 |
|---|---|
| Brief Title: | Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors |
| First Submitted : | April 3, 2019 |
| First Submitted that Met QC Criteria : | April 4, 2019 |
| First Posted : | April 5, 2019 |
| Last Update Submitted that Met QC Criteria : | February 22, 2022 |
| Last Update Posted : | March 9, 2022 |